Radiation Applications

Lutetium-177 / NRG Delivers First Batch Of 10 Patient Doses

By David Dalton
5 February 2021

NRG Delivers First Batch Of 10 Patient Doses
The HFR research reactor at Petten in the Netherlands. Courtesy NRG.
Netherlands-based NRG has delivered lutetium-177 (Lu-177) for the first time to an academic hospital and two pharmaceutical organisations, with plans to increase deliveries and enable further research into use of the isotope.

Want to know more?
Sign up.

Pen Use this content

Tags


Related